GSP 301 nasal spray
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GSP 301 nasal spray, covering 2018-04-06 to 2019-10-08. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR) [Phase 3]